0 false false false false false false false false false true false false false false false false No description of principal activity 2022-10-31 Sage Accounts Production Advanced 2021 - FRS102_2021 260,400 260,400 260,400 xbrli:pure xbrli:shares iso4217:GBP SC748834 2022-10-31 2023-10-31 SC748834 2023-10-31 SC748834 bus:Director1 2022-10-31 2023-10-31 SC748834 core:WithinOneYear 2023-10-31 SC748834 core:ShareCapital 2023-10-31 SC748834 core:RetainedEarningsAccumulatedLosses 2023-10-31 SC748834 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-10-31 SC748834 core:CostValuation core:Non-currentFinancialInstruments 2023-10-31 SC748834 core:Non-currentFinancialInstruments 2023-10-31 SC748834 bus:SmallEntities 2022-10-31 2023-10-31 SC748834 bus:AuditExemptWithAccountantsReport 2022-10-31 2023-10-31 SC748834 bus:FullAccounts 2022-10-31 2023-10-31 SC748834 bus:SmallCompaniesRegimeForAccounts 2022-10-31 2023-10-31 SC748834 bus:PrivateLimitedCompanyLtd 2022-10-31 2023-10-31
COMPANY REGISTRATION NUMBER: SC748834
GG Beauty Ltd
Filleted Unaudited Financial Statements
For the period ended
31 October 2023
GG Beauty Ltd
Statement of Financial Position
31 October 2023
2023
Note
£
Fixed assets
Investments
4
260,400
Current assets
Cash at bank and in hand
100
Creditors: amounts falling due within one year
5
200,000
---------
Net current liabilities
199,900
---------
Total assets less current liabilities
60,500
--------
Capital and reserves
Called up share capital
100
Profit and loss account
60,400
--------
Shareholder funds
60,500
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 6 November 2023 , and are signed on behalf of the board by:
Ms L Guthrie
Director
Company registration number: SC748834
GG Beauty Ltd
Notes to the Financial Statements
Period ended 31 October 2023
1. General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 33 Kittoch Street, East Kilbride, G74 4JW.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
4. Investments
Shares in group undertakings
£
Cost
At 31 October 2022
Additions
260,400
---------
At 31 October 2023
260,400
---------
Impairment
At 31 October 2022 and 31 October 2023
---------
Carrying amount
At 31 October 2023
260,400
---------
5. Creditors: amounts falling due within one year
2023
£
Other creditors
200,000
---------
6. Related party transactions
Control:- The company was under the control of the Ms L Guthrie throughout the period under review. Ms L Guthrie is the sole director and owns the entire issued share capital of the company. Transactions:- No transactions with related parties were undertaken such as are required to be disclosed under Section 1A of FRS 102.